Bioequivalence study of an injection for weight management
Part of Hormones & metabolism clinical trials.
This trial tests if a new injection works the same as the approved version in overweight or obese adults. It may help if you are looking for a weight management treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 55 years old.
- Your weight is at least 110 pounds if male, or 99 pounds if female.
- You are overweight or obese (BMI of 24 or higher).
- You agree to use effective birth control for 3 months after the study dose, and not to donate sperm or eggs.
- You are willing to follow the study rules and sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new injected medicine to see if it is safe and how it works in people who are overweight or obese, as well as in healthy volunteers. It may help with weight loss, but it is an early-phase trial to check safety first.
This study tests an experimental injection called HDM1005 for adults with obesity who do not have diabetes. The goal is to see if it helps with weight loss when combined with diet and exercise.
This study tests whether a change in the manufacturing process for GZR18 (an experimental injectable drug) affects how it works in the body. It may help determine if the new version is as safe and effective as the original.
This trial tests a new injection (BGM1812) for weight loss in people who are overweight or obese. The injection is given under the skin, and the study will see how it works in your body and how safe it is.
This study tests a new weekly injection (BGM0504) to help people with obesity or overweight lose weight. It may be an option if you have not had success with diet and exercise alone and meet certain health criteria.
This study tests an investigational weight-loss injection, IN-B00009, for adults with obesity or overweight who don't have diabetes. It aims to see if the drug is safe and effective for helping you lose weight, along with diet and exercise.
Hear when a new Overweight/Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.